Publications UCOG 93

Assessment of nursing needs and risk management in geriatric oncology

Soins Gerontol. 2013 Jan-Feb;(99):35-9. French

Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301)

J Geriatr Oncol. 2015 May;6(3):233-40. doi: 10.1016/j.jgo.2015.02.002. Epub 2015 Feb 16

Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis

Target Oncol. 2016 Feb;11(1):41-7. doi: 10.1007/s11523-015-0373-x

Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.

Int J Colorectal Dis. 2015 Oct;30(10):1305-10. doi: 10.1007/s00384-015-2296-5. Epub 2015 Jun 23. Review.

Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6

Am J Clin Oncol. 2018 Jan;41(1):73-80. doi: 10.1097/COC.0000000000000233.

Checkpoint inhibitors, the perspectives for elderly patients

Soins Gerontol. 2017 Sep – Oct;22(127):30-33. doi: 10.1016/j.sger.2017.06.010. Review. French

 

 

Impact of the addition of bevacizumab, oxaliplatin or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.

J Clin Oncol, 2017.  35.15_suppl.e15034 Journal of Clinical Oncology 35, no. 15_supp

Is there a clinical benefit of anti-PD-1 in patients older than 75 years with previously treated solid tumour?

J Clin Oncol 34, 2016 (suppl; abstr 3070)

Anti PD-1 (nivolumab, pembrolizumab) or anti PD-L1 (atezolizumab) versus docetaxel for previously treated patients with advanced NSCLC: A meta-analysis.

Bichemotherapy versus single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer: A meta-analysis.

J Clin Oncol 32:5s, 2014 (suppl; abstr 3570)

Prevalence of second primary cancers in a geriatric oncology hospital population.

 

Pain reports and pain medication treatment in elderly patients with cancer: A retrospective cohort study of 311 patients

SIOG 2014 Volume 5, Supplement 2, Page S75

Impact of co-morbidities on gemcitabine as single agent chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

SIOG 2013 Volume 4, Supplement 1, Pages S38–S39

The FROG observatory on the tolerance of chemotherapy in the elderly in real life

SIOG 2013 Volume 4, Supplement 1, Pages S48–S49